- Home
- IMNM vs TPB Comparison
IMNM vs TPB Comparison
Compare IMNM & TPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMNM | TPB |
|---|---|---|
| Founded | 2006 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Tobacco |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.4B |
| IPO Year | 2020 | 2016 |
Fundamental Metrics
Financial Performance| Metric | IMNM | TPB |
|---|---|---|
| Price | $24.77 | $129.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | $31.22 | ★ $115.00 |
| AVG Volume (30 Days) | ★ 2.1M | 315.7K |
| Earning Date | 03-18-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | $9,679,000.00 | ★ $435,716,000.00 |
| Revenue This Year | N/A | $29.51 |
| Revenue Next Year | $11.53 | $11.08 |
| P/E Ratio | ★ N/A | $633.24 |
| Revenue Growth | N/A | ★ 51.72 |
| 52 Week Low | $5.15 | $51.48 |
| 52 Week High | $27.65 | $129.94 |
Technical Indicators
Market Signals| Indicator | IMNM | TPB |
|---|---|---|
| Relative Strength Index (RSI) | 57.35 | 70.65 |
| Support Level | $23.86 | $123.98 |
| Resistance Level | $27.65 | $129.94 |
| Average True Range (ATR) | 1.63 | 3.92 |
| MACD | -0.08 | 0.35 |
| Stochastic Oscillator | 62.94 | 82.60 |
Price Performance
Historical ComparisonAbout IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About TPB Turning Point Brands Inc.
Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.